Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial

Few trials have examined rates of hypersensitivity reactions (HSRs) with intravenous iron formulations used to treat iron deficiency anemia (IDA). This randomized, multicenter, double‐blind clinical trial compared the safety, and efficacy of ferumoxytol versus ferric carboxymaltose (FCM), focusing o...

Descripción completa

Detalles Bibliográficos
Autores principales: Adkinson, N. Franklin, Strauss, William E., Macdougall, Iain C., Bernard, Kristine E., Auerbach, Michael, Kaper, Robert F., Chertow, Glenn M., Krop, Julie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947731/
https://www.ncbi.nlm.nih.gov/pubmed/29417614
http://dx.doi.org/10.1002/ajh.25060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947731/
https://www.ncbi.nlm.nih.gov/pubmed/29417614
http://dx.doi.org/10.1002/ajh.25060

Ejemplares similares